NCT06635629View on ClinicalTrials.gov

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

October 1, 2028

Study Completion Date

January 1, 2029

Conditions
Cushing Syndrome
Interventions
DRUG

Desmopressin

Stimulates ACTH release in Cushing disease

DRUG

Dexamethasone

Inhibits ACTH release in Cushing disease and healthy volunteers

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH